Anne Wojcicki, founder and former CEO of 23andMe, will helm the company again after her nonprofit's purchase was approved.

Previous reports (including ours) said that a company named Regeneron was supposed to be the buyer, but that deal ended up ...

Me Holding said Tuesday that a U.S. bankruptcy court has approved the sale of “substantially all” its assets to TTAM Research ...

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led ...

With hybrid lifestyles now the norm, business trips have become more intentional, more mobile, and surprisingly more restorative.

States with privacy objections to the sale have until July 7 to reach a stay to appeal the case. TTAM, a nonprofit started by ...

The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing ...